These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12410513)

  • 21. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
    Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
    Andersen PE; Bolstad B; Berg KJ; Justesen P; Thayssen P; Kloster YF
    Clin Radiol; 1993 Oct; 48(4):268-72. PubMed ID: 8243006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.
    Sapoval MR; Beyssen BM; Girardot C; Musset MA; Legmann P; Brekke O; Gaux JC
    Clin Radiol; 1996 Mar; 51(3):210-3. PubMed ID: 8605753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney.
    Deray G; Bagnis C; Jacquiaud C; Dubois M; Adabra Y; Jaudon C
    Invest Radiol; 1999 Jan; 34(1):1-4. PubMed ID: 9888047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
    J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Main results of the first comparative clinical studies on Visipaque.
    Grynne BH; Nossen JO; Bolstad B; Borch KW
    Acta Radiol Suppl; 1995; 399():265-70. PubMed ID: 8610526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
    Qureshi NR; den Heijer P; Crijns HJ
    Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
    Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
    J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
    J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast agent-induced thrombophlebitis following leg phlebography: meglumine loxaglate versus meglumine lothalamate.
    Thomas ML; Briggs GM; Kuan BB
    Radiology; 1983 May; 147(2):399-400. PubMed ID: 6340158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.
    Sutton AG; Finn P; Campbell PG; Price DJ; Hall JA; Stewart MJ; Davies A; Linker NJ; De Belder MA
    J Invasive Cardiol; 2003 Mar; 15(3):133-8. PubMed ID: 12612387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive exfoliative dermatitis induced by non-ionic contrast medium Iodixanol (Visipaque) used during percutaneous coronary intervention.
    Choi CU; Rha SW; Suh SY; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2008 Feb; 124(2):e25-7. PubMed ID: 17336410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Hexabrix 320 and Conray 420 for left ventriculography in patients with coronary artery disease.
    Lyons J; Brooks N; Cattell M; Isolani-Smyth E; Balcon R
    Br J Radiol; 1984 Mar; 57(675):209-11. PubMed ID: 6365233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast media-related complications during cardiac catheterization using Hexabrix or Renografin in high-risk patients.
    Feldman RL; Jalowiec DA; Hill JA; Lambert CR
    Am J Cardiol; 1988 Jun; 61(15):1334-7. PubMed ID: 3287884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
    Cho JY; Jeong MH; Hwan Park S; Kim IS; Park KH; Sim DS; Yoon NS; Yoon HJ; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2010 Nov; 56(3):300-6. PubMed ID: 20708903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
    Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
    Palmers Y; De Greef D; Grynne BH; Smits J; Put E
    Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative rheology of low- and iso-osmolarity contrast agents at different temperatures.
    Brunette J; Mongrain R; Rodés-Cabau J; Larose E; Leask R; Bertrand OF
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):78-83. PubMed ID: 18098191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.